Addiction

Who will care for society’s forgotten?

Editor's note: Theresa is a frequent contributor to the New York Times (NYT), and recently authored an Op-Ed on an issue that affects the public at large and the broader health care community. She covers...

Alcohol-related mortality rates on the rise

A new study published in Alcoholism Clinical & Experimental Research reveals that the amount of alcohol-related deaths in the United States has increased between 1999 and 2017. The study examined death certificates of people 16+...

FDA issues warning letter for medication-assisted treatment for opioid use disorder

The U.S. Food and Drug Administration (FDA) recently issued a warning letter to Alkermes, Inc. due to misbranding on the drug Vivitrol, which is used to prevent opioid dependence relapse. The letter was issued...

Legalized recreational marijuana may increase risk for cannabis use disorder

A recent study from JAMA Psychiatry examines this question: Has legalization of recreational marijuana in the United States affected the rates of cannabis use disorder (CUD)? The research was conducted through a repeated, cross-sectional, self-reported...

American Heart Association: E-cigarettes are not safe alternative

The American Heart Association (AHA) recently held its 2019 Scientific Sessions in Philadelphia PA. The sessions covered many topics, but one of the most impactful was a session on e-cigarettes and their adverse health...

Johns Hopkins Center for Psychedelic Research

In early September 2019, Johns Hopkins opened its new Center for Psychedelic and Consciousness Research, which explores the use of psychedelics on brain function, memory, and the brain’s biology. The center explores the use of...

New FDA guidelines on risks of smokeless tobacco products

For the first time ever, the U.S. Food and Drug Administration (FDA) has authorized eight Swedish Match USA, Inc. snus smokeless tobacco products to be marketed through the modified risk tobacco product (MRTP) pathway. Recently,...

How the opioid epidemic affects women

Opioid use disorder (OUD) has become such a prominent topic in today’s society that it’s hard to go one day without hearing news about new death statistics or pending litigation issues, but one aspect...

What works: Managing opioid overdose in the community

Takeaways: To help reduce the rise in opioid prescriptions, misuse, and overdose, healthcare professionals must improve their pain management knowledge, decrease opioid prescriptions as appropriate, and provide patients with the education and resources they...

Guide for using MAT for opioid use disorder

The Agency for Healthcare Research and Quality Academy has developed a new resource for healthcare practitioners to aid in treating opioid use disorder (OUD). The Medication-Assisted Treatment for Opioid Use Disorder Playbook (or the MAT...
np medication treatment opioid disorder

NP role in medication-assisted treatment for opioid use disorder

Combine medication and counseling with shared decision-making to treat addiction. Takeaways: Medication-assisted treatment (MAT), an evidence-based intervention for opioid use disorder and withdrawal symptom management, combines medication with counseling and behavioral therapies. Barriers to MAT include...
Middle-school program reduces young adult substance abuse

Middle-school program reduces young adult substance abuse

Children who participated in the PROSPER (PROmoting School-community-university Partnerships to Enhance Resilience) program over seven years ago showed lower rates of substance abuse after high school graduation, according to a new study conducted by...

Improving nurses’ attitudes toward patients with substance use disorders

Editor’s note: The author uses substance use disorder as a diagnostic term. However, some of the research he cites uses a different term, such as drug addiction or drug misuse. In those cases, to ensure an accurate description of the study,...